Daiki Kayano

545 total citations
37 papers, 370 citations indexed

About

Daiki Kayano is a scholar working on Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daiki Kayano has authored 37 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 17 papers in Cancer Research and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daiki Kayano's work include Cancer, Hypoxia, and Metabolism (16 papers), Adrenal and Paraganglionic Tumors (16 papers) and Neuroblastoma Research and Treatments (12 papers). Daiki Kayano is often cited by papers focused on Cancer, Hypoxia, and Metabolism (16 papers), Adrenal and Paraganglionic Tumors (16 papers) and Neuroblastoma Research and Treatments (12 papers). Daiki Kayano collaborates with scholars based in Japan, United Kingdom and China. Daiki Kayano's co-authors include Seigo Kinuya, Hiroshi Wakabayashi, Anri Inaki, Makoto Fukuoka, Kenichi Nakajima, Junichi Taki, Shinro Matsuo, Tomoko Takahashi, Megumi Jinguji and Hisao Tonami and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of the Neurological Sciences.

In The Last Decade

Daiki Kayano

32 papers receiving 366 citations

Peers

Daiki Kayano
Vania Altrinetti Italy
Dingzhong Hu China
H.R. Marcuse Netherlands
Jennifer Vogel United States
Stefano Panareo Italy
Mohei Abouzied Saudi Arabia
Ulrich Feine Germany
F Claudiani Italy
Koichiro Kajiura Japan
June Key Chung South Korea
Vania Altrinetti Italy
Daiki Kayano
Citations per year, relative to Daiki Kayano Daiki Kayano (= 1×) peers Vania Altrinetti

Countries citing papers authored by Daiki Kayano

Since Specialization
Citations

This map shows the geographic impact of Daiki Kayano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiki Kayano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiki Kayano more than expected).

Fields of papers citing papers by Daiki Kayano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiki Kayano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiki Kayano. The network helps show where Daiki Kayano may publish in the future.

Co-authorship network of co-authors of Daiki Kayano

This figure shows the co-authorship network connecting the top 25 collaborators of Daiki Kayano. A scholar is included among the top collaborators of Daiki Kayano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiki Kayano. Daiki Kayano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujii, Hirofumi, Hiroshi Toyama, Daiki Kayano, Kazunari Ishii, & Seigo Kinuya. (2024). The 13th World Federation of Nuclear Medicine and Biology congress (WFNMB 2022): summarize the past half century and discuss the next half century of WFNMB-. Annals of Nuclear Medicine. 39(2). 87–97.
2.
Wakabayashi, Hiroshi, et al.. (2024). Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry. Scientific Reports. 14(1). 4339–4339. 4 indexed citations
3.
Zhang, Xue, et al.. (2023). Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma. Seminars in Nuclear Medicine. 53(4). 503–516. 5 indexed citations
4.
Inaki, Anri, Tohru Shiga, Yoshito Tsushima, et al.. (2021). An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma. Annals of Nuclear Medicine. 36(3). 267–278. 11 indexed citations
5.
6.
Wakabayashi, Hiroshi, Daiki Kayano, Anri Inaki, et al.. (2021). Prognostic factors for refractory pheochromocytoma and paraganglioma after 131I-metaiodobenzylguanidine therapy. Annals of Nuclear Medicine. 36(1). 61–69. 3 indexed citations
7.
Wakabayashi, Hiroshi, Daiki Kayano, Anri Inaki, et al.. (2020). High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience. Annals of Nuclear Medicine. 34(11). 840–846. 4 indexed citations
8.
Kayano, Daiki, Hiroshi Wakabayashi, Kenichi Nakajima, et al.. (2020). High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan. Annals of Nuclear Medicine. 34(6). 397–406. 8 indexed citations
9.
10.
Kayano, Daiki & Seigo Kinuya. (2015). Iodine‐131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective. The Scientific World JOURNAL. 2015(1). 189135–189135. 30 indexed citations
11.
Kayano, Daiki, et al.. (2014). I-131 MIBG therapy for malignant pheochromocytoma. 32(1). 39–43.
12.
Konishi, Takahiro, Kenichi Nakajima, Shinro Matsuo, et al.. (2014). Optimization of attenuation and scatter corrections in sentinel lymph node scintigraphy using SPECT/CT systems. Annals of Nuclear Medicine. 29(3). 248–255. 6 indexed citations
13.
Wakabayashi, Hiroshi, Junichi Taki, Anri Inaki, et al.. (2013). Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma. Annals of Nuclear Medicine. 27(9). 839–846. 27 indexed citations
14.
Sato, Yuya, Hidemitsu Kurosawa, Keitaro Fukushima, et al.. (2012). I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 38(1). 53–53. 4 indexed citations
15.
Watanabe, Naoto, Tomoko Takahashi, Mitsuru Taniguchi, et al.. (2012). Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using γ-H2AX foci of DNA damage in lymphocytes. Annals of Nuclear Medicine. 27(3). 233–238. 23 indexed citations
16.
Wakabayashi, Hiroshi, Kenichi Nakajima, Makoto Fukuoka, et al.. (2011). Double-phase 131I whole body scan and 131I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification. Annals of Nuclear Medicine. 25(9). 609–615. 17 indexed citations
17.
Kayano, Daiki, Junichi Taki, Hiroshi Wakabayashi, & Seigo Kinuya. (2011). Tc-99m Human Serum Albumin Lymphoscintigraphy With SPECT/CT in Chylothorax. Clinical Nuclear Medicine. 36(11). 1056–1057. 11 indexed citations
18.
Kayano, Daiki, Kenichi Nakajima, Hiroshi Ohtake, & Seigo Kinuya. (2009). Gated myocardial perfusion SPECT for preoperative risk stratification in patients with noncardiac vascular disease. Annals of Nuclear Medicine. 23(2). 173–181. 3 indexed citations
19.
Higuchi, Takahiro, Atsuhiro Kawashima, Makoto Fukuoka, et al.. (2007). Effect of Postconditioning on Myocardial 99mTc-Annexin-V Uptake: Comparison with Ischemic Preconditioning and Caspase Inhibitor Treatment. Journal of Nuclear Medicine. 48(8). 1301–1307. 19 indexed citations
20.
Nakajima, Kenichi, et al.. (2006). Fluctuation of adenosine concentration by modes of intravenous infusion based on mathematical simulation and experiments. Annals of Nuclear Medicine. 20(7). 485–491. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vania Altrinetti Breakdown of academic impact, for papers by Dingzhong Hu Breakdown of academic impact, for papers by H.R. Marcuse Breakdown of academic impact, for papers by Jennifer Vogel Breakdown of academic impact, for papers by Stefano Panareo Breakdown of academic impact, for papers by Mohei Abouzied Breakdown of academic impact, for papers by Ulrich Feine Breakdown of academic impact, for papers by F Claudiani Breakdown of academic impact, for papers by Koichiro Kajiura Breakdown of academic impact, for papers by June Key Chung
Rankless by CCL
2026